Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Längle, Friedrich
PARC, NCT04894643: Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer	Recruiting	N/A	10	Europe	Proton Ions, Nab-PACLitaxel, Abraxane®, Gemcitabine, Capecitabine, Surgical resection of the pancreas (when feasible)	EBG MedAustron GmbH, Landesklinkum Wiener Neustadt	Pancreatic Cancer, Proton Therapy	12/24	12/26
ORSY, NCT05174910: Investigation of the Benefit of Using an Autologous Platelet-rich Fibrin Matrix (Obsidian ASG®) for Treatment of Anastomosis During Rectal Surgery	Active, not recruiting	N/A	250	Europe, RoW	Obsidian ASG	Vivostat, Raffeiner GmbH, European Commission, AF Schimetta GMbH, Rivolution GmbH	Anastomotic Leak Rectum	10/24	12/24

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Längle, Friedrich
PARC, NCT04894643: Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer	Recruiting	N/A	10	Europe	Proton Ions, Nab-PACLitaxel, Abraxane®, Gemcitabine, Capecitabine, Surgical resection of the pancreas (when feasible)	EBG MedAustron GmbH, Landesklinkum Wiener Neustadt	Pancreatic Cancer, Proton Therapy	12/24	12/26
ORSY, NCT05174910: Investigation of the Benefit of Using an Autologous Platelet-rich Fibrin Matrix (Obsidian ASG®) for Treatment of Anastomosis During Rectal Surgery	Active, not recruiting	N/A	250	Europe, RoW	Obsidian ASG	Vivostat, Raffeiner GmbH, European Commission, AF Schimetta GMbH, Rivolution GmbH	Anastomotic Leak Rectum	10/24	12/24